How did Twist Bioscience's revenue and expenses trend in Q1 2025?

In Q1 2025, Twist Bioscience's revenue was $92.79 million, with operating expenses of $23.92 million, R&D expenses of $63.67 million, and selling, general, and administrative expenses also of $63.67 million. |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|R&D Expenses|Total Revenue|Operating Expenses|market_code| |---|---|---|---|---|---|---|---|---| |TWST|TWST.O|Twist Bioscience|2024 Q2|5.5622E7|2.4149E7|7.5302E7||185| |TWST|TWST.O|Twist Bioscience|2024 Q3|5.6794E7|2.2469E7|8.1464E7||185| |TWST|TWST.O|Twist Bioscience|2024 Q4|5.3142E7|2.1134E7|8.471E7||185| |TWST|TWST.O|Twist Bioscience|2025 Q1|5.6177E7|2.1307E7|8.8713E7||185|